Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

McMaster University

$135,000.00

Hormonal Contraceptives, the Vaginal Microbiome, and Susceptibility to Sexually Transmitted Infections

EF 2016-17

Résumé
When it comes to gender, not all things are equal. In terms of reproductive health, women are at a higher risk than men for a number of sexually transmitted infections (STIs). Women are at an increased risk of Herpes and Chlamydia, and they are at a 2-5 times greater risk of acquiring Human Immunodeficiency Virus (HIV) than men. There are several reasons for this including anatomy, hormones, and the menstrual cycle. Recent research has shown that another reason why women are at increased risk of STIs might be the bacteria that live in the vagina, that play a central role in protecting against infections. The bacteria are controlled by hormones, which are also the active ingredients in birth control. In fact, there are many studies that show that women may be at an increased risk of getting HIV from sexual contact if they are on the injectable birth control (Depo-Provera). In this proposal, we want to know if Depo-Provera is increasing diversity of the bacteria in the vagina, and making it easier for STIs like HIV to infect women. The goals of this project are to 1) look at how Depo-Provera affects the bacteria living in the vaginal tract which serve to protect against infection, 2) determine if giving Depo-Provera to mice with a human immune system increases bacterial diversity in the vagina and increases their chances of an HIV infection, and 3) show that an experimental change favouring more diverse bacteria in the vagina makes it easier for HIV to infect humanized mice. We want to understand if women on Depo-Provera have more "unhealthy" bacteria in their vaginal canals, and if Depo-Provera and/or "unhealthy" bacteria make it easier for HIV infection to occur in a humanized mouse model of infection. There are over 100 million women world-wide who use contraceptives, and this research will help better understand STIs in women and identify new factors that affect the risk of STIs. This will allow women to make more informed choices about their birth control method
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
361679
Name
Wessels Jocelyn M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Hormonal Contraceptives, the Vaginal Microbiome, and Susceptibility to Sexually Transmitted Infections
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Depot-Medroxyprogesterone Acetate (Dmpa); Estrogen; Female Reproductive Tract; Hiv Transmission; Progesterone; Sexually Transmitted Infections; Vaginal Microbiome; Women'S Reproductive Health
Abstract
When it comes to gender, not all things are equal. In terms of reproductive health, women are at a higher risk than men for a number of sexually transmitted infections (STIs). Women are at an increased risk of Herpes and Chlamydia, and they are at a 2-5 times greater risk of acquiring Human Immunodeficiency Virus (HIV) than men. There are several reasons for this including anatomy, hormones, and the menstrual cycle. Recent research has shown that another reason why women are at increased risk of STIs might be the bacteria that live in the vagina, that play a central role in protecting against infections. The bacteria are controlled by hormones, which are also the active ingredients in birth control. In fact, there are many studies that show that women may be at an increased risk of getting HIV from sexual contact if they are on the injectable birth control (Depo-Provera). In this proposal, we want to know if Depo-Provera is increasing diversity of the bacteria in the vagina, and making it easier for STIs like HIV to infect women. The goals of this project are to 1) look at how Depo-Provera affects the bacteria living in the vaginal tract which serve to protect against infection, 2) determine if giving Depo-Provera to mice with a human immune system increases bacterial diversity in the vagina and increases their chances of an HIV infection, and 3) show that an experimental change favouring more diverse bacteria in the vagina makes it easier for HIV to infect humanized mice. We want to understand if women on Depo-Provera have more "unhealthy" bacteria in their vaginal canals, and if Depo-Provera and/or "unhealthy" bacteria make it easier for HIV infection to occur in a humanized mouse model of infection. There are over 100 million women world-wide who use contraceptives, and this research will help better understand STIs in women and identify new factors that affect the risk of STIs. This will allow women to make more informed choices about their birth control method
Competitiondate
201611
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wessels, Jocelyn M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~